NCT06935864 Tissue Expression of Krüppel-Like Factors 4 and 7 in Bone Tumors
| NCT ID | NCT06935864 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Osteosarcoma in Children |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-08-16 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2024-08-16 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The current study is to assess the prognostic value of Krüppel-like factors 4 and 7 in bone tumors, and its role in the disease progression.
Eligibility Criteria
Inclusion Criteria: Age: children, young adolescents younger than 15 years, and young adults (15 to 39 years) Gender: Males and female. Histologically confirmed patients with skeletal or extra-skeletal OS or ES. Both localized and metastatic disease stages. Exclusion Criteria: Patients with second malignant bone sarcoma. Patients with benign bone tumors.
Contact & Investigator
Fatma S E Ebeid
PRINCIPAL INVESTIGATOR
Faculty of Medicine Ain Shams University
Frequently Asked Questions
Who can join the NCT06935864 clinical trial?
This trial is open to participants of all sexes, aged 1 Month or older, up to 39 Years, studying Osteosarcoma in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06935864 currently recruiting?
Yes, NCT06935864 is actively recruiting participants. Contact the research team at fatmaebeid@med.asu.edu.eg for enrollment information.
Where is the NCT06935864 trial being conducted?
This trial is being conducted at Cairo, Egypt, Cairo, Egypt.
Who is sponsoring the NCT06935864 clinical trial?
NCT06935864 is sponsored by Ain Shams University. The principal investigator is Fatma S E Ebeid at Faculty of Medicine Ain Shams University. The trial plans to enroll 30 participants.